Page last updated: 2024-09-03

rhenium-186 hedp and Pain

rhenium-186 hedp has been researched along with Pain in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (6.67)18.2507
2000's20 (66.67)29.6817
2010's8 (26.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, S; Dash, A; Kameswaran, M; Kumar, C; Mallia, MB; Sarma, HD; Sharma, R1
Amoui, M; Asli, IN; Assadi, M; Kalantari, BA; Mirzaee, HR; Pirayesh, E; Rakhsha, A; Shafiei, B; Tabei, F1
Beekman, FJ; Bloemendal, HJ; Breukels, OB; de Graaf, H; de Klerk, JM; Hendrikse, NH; Lange, R; Malingré, MM; Rummenie, RG; ter Heine, R; van den Berg, L; van der Westerlaken, MM; Wakker, AM; Wielders, JP1
Aswathy, KK; Banerjee, S; Kalarikal, R; Kamaleshwaran, KK; Kameswaran, M; Mallia, MB; Shinto, AS1
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A2
Chen, S; Cheng, A; Dong, M; Yin, D; Zhang, Y1
Alsharif, A; Boni, G; Borsò, E; Chiacchio, S; Greco, C; Grosso, M; Lorenzoni, A; Manca, G; Mariani, G; Mazzarri, S; Nyakale, N; Volterrani, D1
Aras, G; Gümüş-Akay, G; Ibiş, E; Köroğlu, R; Küçük, O; Ozkal-Baydin, P; Rüstemoğlu, A; Sunguroğlu, A; Varol, N; Yüksel, S1
Kotzerke, J; Kropp, J; Liepe, K; Runge, R1
Bandurski, T; Derejko, M; Romanowicz, G; Scheffler, J1
Endo, K; Li, S; Liu, J; Tanada, S; Tian, M; Zhang, H1
de Klerk, JM; Lam, MG; van Rijk, PP1
Kotzerke, J; Liepe, K; Runge, R1
Anagnostopoulou, US; Datseris, EI; Leondi, AH; Leontopoulou, SA; Papadaki, EK; Rapti, AS; Souvatzoglou, MA; Zerva, CJ1
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP1
Bergomi, S; Maini, CL; Romano, L; Sciuto, R1
Antonini, N; Hoefnagel, CA; Horenblas, S; Valdes Olmos, RA; van der Poel, HG1
Benassi, M; D'Andrea, M; Maini, CL; Pasqualoni, R; Sciuto, R; Strigari, L1
Kotzerke, J; Liepe, K1
de Klerk, JM; Lam, MG; van Rijk, PP; Zonnenberg, BA1
Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P1
Holle, LH; Humke, U; Kirsch, CM; Oberhausen, E; Trampert, L; Ziegler, M1
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A1
Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R1
Franke, WG; Hliscs, R; Kropp, J; Liepe, K1
Bestagno, M; Cittanti, C; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A1
Banerjee, S; Chaudhari, PR; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Unnikrishnan, TP1
Bangard, M; Biersack, HJ; Menzel, C; Palmedo, H; Risse, J; Rockstroh, JK; Schliefer, K1
Li, S; Liu, J; Tian, M; Wang, J; Zhang, H; Zheng, X1

Reviews

5 review(s) available for rhenium-186 hedp and Pain

ArticleYear
Radionuclide therapy and integrated protocols for bone metastases.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4

    Topics: Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Patient Selection; Radioimmunotherapy; Radiopharmaceuticals; Technetium Tc 99m Medronate; Treatment Outcome

2011
Application of rhenium-188 HEDP in bone metastases therapy.
    Nuclear medicine review. Central & Eastern Europe, 2003, Volume: 6, Issue:1

    Topics: Bone Neoplasms; Etidronic Acid; Humans; Leukopenia; Organometallic Compounds; Pain; Palliative Care; Practice Patterns, Physicians'; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Treatment Outcome

2003
186Re-HEDP for metastatic bone pain in breast cancer patients.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31 Suppl 1

    Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Maximum Tolerated Dose; Organometallic Compounds; Pain; Palliative Care; Radiation Injuries; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome

2004
Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases.
    Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:4 Suppl

    Topics: Bone Neoplasms; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radionuclide Imaging; Strontium

2003
Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
    Anti-cancer agents in medicinal chemistry, 2007, Volume: 7, Issue:4

    Topics: Bone Neoplasms; Clinical Trials as Topic; Etidronic Acid; Humans; Medical Oncology; Models, Chemical; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Pain; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Strontium; Treatment Outcome

2007

Trials

10 trial(s) available for rhenium-186 hedp and Pain

ArticleYear
Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Journal of nuclear medicine technology, 2013, Volume: 41, Issue:3

    Topics: Adult; Aged; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Radiation Dosage

2013
The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
    Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:2

    Topics: Blood Cell Count; Bone Neoplasms; Electrocardiography; Etidronic Acid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Pain; Pain Measurement; Palliative Care

2011
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
    British journal of cancer, 2003, Aug-18, Volume: 89, Issue:4

    Topics: Aged; Aged, 80 and over; Blood Cell Count; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome

2003
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:1

    Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Surveys and Questionnaires; Time Factors; Treatment Outcome

2005
Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:3

    Topics: Bone Neoplasms; Carcinoma; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Patient Selection; Radiopharmaceuticals; Treatment Outcome

2004
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium

2005
A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Nuclear medicine communications, 2007, Volume: 28, Issue:8

    Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Prospective Studies; Prostatic Neoplasms; Quality of Life; Radiopharmaceuticals; Strontium; Treatment Outcome

2007
[Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Nuklearmedizin. Nuclear medicine, 1996, Volume: 35, Issue:2

    Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed

1996
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6

    Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed

2000
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study.
    Radiology, 2001, Volume: 221, Issue:1

    Topics: Arthritis, Rheumatoid; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Prospective Studies; Radioisotopes; Rhenium; Treatment Failure

2001

Other Studies

15 other study(ies) available for rhenium-186 hedp and Pain

ArticleYear
In Vitro Evaluation of
    Cancer biotherapy & radiopharmaceuticals, 2017, Volume: 32, Issue:5

    Topics: Bone Neoplasms; Cell Culture Techniques; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain; Radiopharmaceuticals

2017
Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
    International journal of pharmaceutics, 2014, Apr-25, Volume: 465, Issue:1-2

    Topics: Animals; Bone Neoplasms; Etidronic Acid; Feasibility Studies; Humans; Male; Mice; Organometallic Compounds; Pain; Prostatic Neoplasms; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Translational Research, Biomedical

2014
A Freeze-Dried Kit for the Preparation of (188)Re-HEDP for Bone Pain Palliation: Preparation and Preliminary Clinical Evaluation.
    Cancer biotherapy & radiopharmaceuticals, 2016, Volume: 31, Issue:4

    Topics: Bone Neoplasms; Etidronic Acid; Freeze Drying; Humans; Organometallic Compounds; Pain; Palliative Care; Radiopharmaceuticals; Reagent Kits, Diagnostic

2016
Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice.
    Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analgesics; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Treatment Outcome; Zoledronic Acid

2009
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium

2011
Potential genotoxic effect of 186Re-HEDP on human lymphocyte cells: in-vitro evaluation with micronucleus-FISH analysis.
    Nuclear medicine communications, 2012, Volume: 33, Issue:4

    Topics: Adult; Bone Neoplasms; Etidronic Acid; Female; Humans; In Situ Hybridization, Fluorescence; Lymphocytes; Male; Middle Aged; Organometallic Compounds; Pain; Radioisotopes; Young Adult

2012
Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
    Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5

    Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium

2003
Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer.
    Urologia internationalis, 2006, Volume: 77, Issue:1

    Topics: Aged; Bone Neoplasms; Etidronic Acid; Hemoglobins; Humans; Male; Organometallic Compounds; Pain; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Strontium Radioisotopes

2006
Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:7

    Topics: Bone Neoplasms; Computer Simulation; Etidronic Acid; Humans; Models, Biological; Monte Carlo Method; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Strontium; Treatment Outcome

2007
[Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)].
    Der Urologe. Ausg. A, 1997, Volume: 36, Issue:6

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Rhenium

1997
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Annals of nuclear medicine, 2000, Volume: 14, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium

2000
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:11

    Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate

2000
A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:7

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Etidronic Acid; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes

2001
186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation.
    Nuclear medicine and biology, 2001, Volume: 28, Issue:6

    Topics: Analgesics; Animals; Bone Neoplasms; Etidronic Acid; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Male; Organometallic Compounds; Organophosphonates; Pain; Rabbits; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution

2001
Rhenium-188 HEDP to treat painful bone metastases.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:11

    Topics: Bone Neoplasms; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Platelet Count; Radionuclide Imaging; Radiopharmaceuticals; Rhenium

2001